Two studies recently published in Veterinary and Animal Science have raised questions about the welfare of Atlantic salmon during thermal delousing treatments. Results of the studies found that exposure to warm water caused a highly aversive reaction that was likely attributed to the sudden change in temperature, not the presence of other fish or manual handling.
The recent merger of Scan Aqua with MSD Animal Health is sure to provide some exciting opportunities in the Norwegian and European aquaculture markets. MSD Animal Health offers one of the industry's most innovative product portfolios, from disease prevention to disease treatment and control. MSD Animal Health's philosophy around humane treatment of animals through welfare considered practices is equal to that of AQUI-S New Zealand’s, making them ideal partners moving forward.
The role of AQUI-S NZ Ltd. will remain unchanged with our primary focus being the production of high-quality veterinary GMP anaesthetics and superior support to both end-users and distributors alike.
Please don’t hesitate to contact MSD Animal Health or AQUI-S New Zealand Ltd today to see how we can work for you.
We are excited to announce the appointment of Veterquimica S.A. as the new distributor for AQUI-S® products in Chile.
Veterquimica S.A. has more than 45 years experience in the market and has business branches in Animal Health, Animal Nutrition, Hygiene and Biosecurity, and Service Laboratory. Within the aquaculture segment, Veterquimica S.A. is actively developing and selling products for fish health, fish nutrition and farm biosecurity/hygiene. This makes Veterquimica S.A. an ideal partner for our AQUI-S aquatic sedative.
Bathing salmon in freshwater is a commercially important tool for the control of various diseases including Sea Lice and Amoebic gill disease (AGD).
These treatment operations are well known to be stressful to the fish which in turn causes significant quality issues during and post-treatment. A recent study conducted in Norway has further highlighted exactly how stressful these procedures are in terms of cortisol release. If you would like more information from this study or other related work, contact AQUI-S NEW ZEALAND Ltd. directly.
Disease treatments in aquaculture have become a frequent and essential part of production.
In the salmon industry the frequency of treatments has increased whilst the effectiveness, in most cases, has reduced. This is leading to higher costs associated with the practice and higher mortalities.